Data gathered: April 1
Alternative Data for SPDR S&P Biotech ETF
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 54 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 468 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 26,702 | Sign up | Sign up | Sign up |
| Twitter Mentions | 195 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
About SPDR S&P Biotech ETF
The Fund seeks to replicate as closely as possible the performance of an index derived from the biotechnology segment of a U.S. total market composite index.
| Price | $78.16 |
| Target Price | Sign up |
| Volume | 17,080,000 |
| Year Range | $78.16 - $104.18 |
| Industry | ETF |
In the news
 |
Avantax Advisory Services Inc. Has $644,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)March 22 - ETF Daily News |
|
Proficio Capital Partners LLC Has $979,000 Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)March 22 - ETF Daily News |
|
Zurcher Kantonalbank Zurich Cantonalbank Sells 276 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)March 17 - ETF Daily News |
 |
Invest In A New Biotech Bull Market With XBI And IBBMarch 1 - SeekingAlpha |
|
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Ieq Capital LLCFebruary 28 - ETF Daily News |
|
Truist Financial Corp Buys 9,746 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)February 25 - ETF Daily News |
Similar ETFs
XBI - Top holdings
| Asset | % Weight | Shares | Price | AI Score | |
|---|---|---|---|---|---|
 |
Alnylam PharmaceuticalsALNY |
2.7437% | 559,241 | $255.76 5.3% | 55 |
 |
INSM |
2.57509% | 1,831,010 | ||
|
NBIX |
2.56509% | 1,242,974 | ||
|
NTRA |
2.51868% | 938,199 | ||
 |
Vertex PharmaceuticalsVRTX |
2.48918% | 273,616 | $484.74 0% | 68 |
 |
United TherapeuticsUTHR |
2.46165% | 441,481 | $306.88 0.5% | 60 |
 |
BiogenBIIB |
2.45664% | 967,064 | $132.03 3.5% | 43 |
 |
AmgenAMGN |
2.40126% | 433,819 | $306.92 1.5% | 47 |
 |
Gilead SciencesGILD |
2.39308% | 1,189,250 | $111.28 0.7% | 53 |
 |
Exact SciencesEXAS |
2.38211% | 2,924,886 | $43.45 0.4% | 36 |
Read more about SPDR S&P Biotech ETF (XBI) and its price prediction, technical analysis, sentiment, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions & news mentions.
What is the current stock price of SPDR S&P Biotech ETF?
Currently, the price of one share of SPDR S&P Biotech ETF stock is $78.16.
How can I analyze the XBI price chart for investment decisions?
The XBI price chart above provides a comprehensive visual representation of SPDR S&P Biotech ETF's performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling SPDR S&P Biotech ETF. Our platform offers an up-to-date XBI stock price chart, along with technical data analysis and alternative data insights.
What are some of the similar ETFs to SPDR S&P Biotech ETF?
Some of the similar ETF as SPDR S&P Biotech ETF are SPDR S&P 500 ETF, Invesco QQQ, Vanguard Total Stock Market Index, Technology Select Sector SPDR, and SPDR Gold Shares.
.